A biotechnology company with a proprietary portfolio of Cannabis-based candidate therapies and a provider of contract manufacturing services for the global medical and pharmaceutical Cannabis industries.


Farkel was founded in 2018 by renowned healthcare executives and experienced investors with laboratories at the Panarea Medical Cannabis Hub in Parque de Las Ciencias Trade Free Zone in Uruguay. The Panarea Hub is also the selected site of other global medical Cannabis companies, CROs, and agricultural and healthcare diagnostics services providers which, together, deliver services and infrastructure to accelerate the development of scientifically validated healthcare assets.

For more information, visit: www.farkelpharma.com

A tax free-licensed healthcare conglomerate for clinical research, diagnostics and medical Cannabis R&D, manufacturing and exportation.

Two business units support discovery to exportation of medical, pharmaceutical, and consumer goods including Cannabis-based products.

Medical Cannabis Hub: cultivation, R&D, APIs, GMP contract manufacturing, clinical research services and exportation capabilities.

Diagnostics Hub: agricultural molecular diagnostics, clinical & molecular diagnostics, and clinical research services.

Our Tenants